Pulmonary Function After Convex Thoracoplasty in Adolescent Idiopathic Scoliosis Patients Treated by Posteromedial Translation.

STUDY DESIGN: Retrospective cohort study. OBJECTIVE: To analyze the morbidity of thoracoplasty, and more specifically its effect on pulmonary function, after surgery with hybrid constructs using sublaminar bands in adolescent idiopathic scoliosis (AIS). BACKGROUND: Cosmetic concern is one of the main reasons to consider surgery in adolescent idiopathic scoliosis. Several studies have demonstrated significant improvement of self-image scores after thoracoplasty. However, consequences of thoracoplasty on pulmonary function (ie, pulmonary function tests [PFTs]) remain controversial. METHODS: After institutional review board approval, 96 consecutive AIS patients with thoracic curves (Lenke 1 and 2) were included between January 2014 and November 2015. All patients underwent low-dose stereoradiography with 3D reconstructions. Surgical procedure was the same in all patients: posterior correction using posteromedial translation technique with hybrid constructs (thoracic sublaminar bands and lumbar pedicle screws). Pulmonary function was explored with PFTs (forced vital capacity, forced expiratory volume in 1 second, and total lung capacity). Radiographic parameters and PFT results were compared between patients with and without thoracoplasty preoperatively and at two years postoperation. RESULTS: Mean age was 15 ± 2 years, and body mass index averaged 18.8 ± 2.6. Thirty-six patients (37.5%) underwent thoracoplasty. Both groups were comparable preoperatively regarding demographic data, radiographic parameters, and PFT results. No significant difference was found between groups regarding postoperative correction rates. At the two-year follow-up, PFT results were similar to the preoperative ones and no difference was observed between groups. However, pleural effusions were reported in 26 patients (72%) on chest radiographs. Only one pleural effusion due to thoracoplasty required drainage. CONCLUSION: Results of the current study demonstrated that thoracoplasty associated with posteromedial translation technique did not alter PFT results at two years postoperation. The morbidity of the procedure is limited, and it can therefore be considered in patients with high cosmetic demand and significant residual rib hump after main curve correction. However, hump height and pain evaluation would be interesting data in a prospective study. LEVEL OF EVIDENCE: Level IV.

Evaluation of the analgesia nociception index for monitoring intraoperative analgesia in children.

BACKGROUND: Intraoperative analgesia is still administered without guidance. Anaesthetists decide upon dosing on the basis of mean population opioid pharmacological studies and in response to variations in haemodynamic status. However, those techniques have been shown to be imprecise. We assessed the diagnostic value of monitoring the analgesia nociception index (ANI) to detect surgical stimulation in children. METHODS: This was an observational study of 2- to 12-yr-old patients 5 min before and after surgical incision. Hypnosis was maintained with sevoflurane and guided by bispectral index. Intraoperative analgesia was administered as a remifentanil infusion titrated to variations in haemodynamic parameters, and ANI monitor values were recorded. ANI parameters assessed included instantaneous ANI (ANIi), mean ANI (ANIm), and the relative change of ANIi to ANIm (DeltaANI=ANIi-ANIm/ANIm). Statistical analyses were performed using receiver-operating-characteristic analysis with determination of the area under the receiver operating characteristic (AUROC) curve and the grey zone. RESULTS: Overall, 49 subjects were included in this study. The AUROC was 0.755 (0.738-0.772), 0.771 (0.755-0.787), and 0.756 (0.738-0.774) for ANIi, ANIm, and DeltaANI, respectively. The threshold of ANI parameters indicating the presence of noxious surgical stimuli was ≤53%, ≤56%, and ≤-13.3% for ANIi, ANIm, and DeltaANI, respectively. The percentage of subjects in the inconclusive zone was 41%, 51%, and 33% for ANIi, ANIm, and DeltaANI, respectively. CONCLUSIONS: ANI has diagnostic value for detecting surgical stimuli in children.

Ketamine for chronic non-cancer pain: A meta-analysis and trial sequential analysis of randomized controlled trials.

BACKGROUND: Ketamine has been suggested to be efficient in relieving chronic pain. However, there is inconsistency across studies investigating the effect of ketamine for chronic pain management. We aimed to perform a meta-analysis in order to assess the efficacy of this compound during chronic non-cancer pain conditions. METHODS: The study consisted in a meta-analysis of clinical trials comparing ketamine to a placebo during chronic non-cancer pain. The primary endpoint of this study was pain relief 4 weeks after the beginning of treatment. Secondary outcomes were: pain relief 1, 2, 8 and 12 weeks after the beginning of treatment and incidence of psychedelic manifestations. RESULTS: Six studies were included in this meta-analysis. Overall, 99 patients received ketamine and 96 received placebo. Ketamine did not decrease pain intensity at 4 weeks (MD (on a 0 to 10 scale) = -1.12 [-2.33, 0.09], GRADE evidence: very low). However, analysing studies with no high-risk bias found ketamine to decrease pain intensity at 4 weeks and increased the level of GRADE evidence to moderate. Trial sequential analysis confirmed the overall result and revealed the lack of power of this meta-analysis. Ketamine also decreased pain intensity at all other evaluated points in time. Ketamine increased the incidence of psychedelic manifestations in comparison to placebo. CONCLUSION: Results of this meta-analysis found moderate evidence suggesting the efficacy of ketamine during chronic pain. Further studies are warranted to conclude about the effect of ketamine during chronic pain conditions and to determine optimal administration regimes of this agent during this condition. SIGNIFICANCE: Ketamine has been found interesting for managing chronic pain. We performed a meta-analysis aiming to confirm those results. Ketamine was found efficient in alleviating pain up to 12 weeks after the beginning of treatment. However, overall evidence favouring the use of this compound was very low.